Skip Nav Destination
Issues
February 2013
ISSN 0378-584X
EISSN 1423-0240
Journal Name Change
Continued with Vol. 37 (2014) as: Oncology Research and Treatment.
Onkologie 2013, Vol. 36, No. 1-2
Editorial Board
Editorial Board
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 1.
https://doi.org/10.1159/000325279
Contents ・ Inhalt
Original Article · Originalarbeit
Creation and Utilization of a Digital Database for Nasal Prosthesis Models
Subject Area:
Oncology
Bernd Reitemeier; Bela Götzel; Christine Schöne; Frank Stockmann; Rainer Müller; Jana Lexmann; Heike Meissner
Onkologie (2013) 36 (1-2): 7–11.
https://doi.org/10.1159/000346668
Nipple Discharge: Role of Ductoscopy in Comparison with Standard Diagnostic Tests
Subject Area:
Oncology
Christine Albrecht; Franziska Thele; Susanne Grunwald; Thomas Kohlmann; Katrin Hegenscheid; Kirsten Utpatel; Marek Zygmunt; Ralf Ohlinger
Onkologie (2013) 36 (1-2): 12–16.
https://doi.org/10.1159/000346639
Gastrointestinal Stromal Tumors in Turkey: Experiences from 3 Centers
Subject Area:
Oncology
Fatih Selcukbiricik; Suayip Yalçın; Deniz Tural; Sibel Erdamar; Gokhan Demir; Gülen Doğusoy; Nil Molinas Mandel
Onkologie (2013) 36 (1-2): 18–24.
https://doi.org/10.1159/000346673
Markers CD40, VEGF, AKT, PI3K, and S100 Correlate with Tumor Stage in Gastric Cancer
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 26–31.
https://doi.org/10.1159/000346675
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies
Subject Area:
Oncology
Elisa Gallerani; Richard Cathomas; Cristiana Sessa; Tiziana Digena; Anna Amalia Bartosek; Laura Dal Zotto; Roger von Moos
Onkologie (2013) 36 (1-2): 40–45.
https://doi.org/10.1159/000346671
Case Report · Kasuistik
Acute Stroke Secondary to Carotid Artery Dissection in a Patient with Germ Cell Tumour: Did Cisplatin Play a Role?
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 46–48.
https://doi.org/10.1159/000346676
Fatal Cisplatin Overdose in the Treatment of Mediastinal Lymphoma with the ESHAP Regimen – Analysis of the Causes of the Adverse Drug Event
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 49–52.
https://doi.org/10.1159/000346677
Review Article · Übersichtsarbeit
Model Calculations to Quantify Clinical and Economic Effects of Pathogen Inactivation in Platelet Concentrates
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 53–59.
https://doi.org/10.1159/000346309
Further Section · Weitere Sektionen
PharmaForum
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 68–69.
https://doi.org/10.1159/000312595
Pharma News / PharmaTicker
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 70–72.
https://doi.org/10.1159/000176390
Meetings and Conferences · Tagungen und Kongresse
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 73–74.
https://doi.org/10.1159/000312417
Guidelines for Authors
Subject Area:
Oncology
Onkologie (2013) 36 (1-2): 75.
https://doi.org/10.1159/000312418
